News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
05-Oct-2011 - APEIRON Biologics AG and the Children s Oncology Group (COG) announced a collaboration on conducting a clinical phase II study in neuroblastoma patients. In the course of this new clinical trial, Apeiron´s APN301, a recombinant fusion protein consisting of the humanized anti-GD2 monoclonal ...
27-Jun-2011 - Apeiron Biologics AG (Apeiron) announced the conclusion of an agreement with the Children's Cancer Research Institute (CCRI) and the European Neuroblastoma Research Network (SIOPEN). Thereby, Apeiron obtains the rights to further develop, file for regulatory approval and market the antibody ...
17-Mar-2011 - APEIRON Biologics AG announced that it has entered into an exclusive option to license from the Cleveland Clinic a number of novel compounds. These compounds are currently in development at Cleveland Clinic as drug candidates for treatment of various cancers, designed to fight cancer based on ...
03-Feb-2011 - Vienna-based biotech company Apeiron Biologics AG strengthens its cancer immunotherapy portfolio by acquiring rights to further develop and commercialize the immunocytokine hu14.18-IL2 from Merck KGaA, Germany. This investigational antibody-based biologic has met drug development checkpoints to ...
09-Nov-2010 - APEIRON Biologics AG announced that, as part of its effort to broaden its current project portfolio, it has concluded an agreement with Polymun Scientific GmbH granting Apeiron exclusive rights to recombinant human Super Oxide Dismutase (SOD). SOD, a naturally occurring enzyme with important, ...
28-Oct-2010 - Evotec AG announced that it has entered into a collaboration with Apeiron Biologics AG, to initially identify small molecule modulators of DREAM (Downstream Regulatory Element Antagonistic Modulator), a novel target involved in perception of various pain mechanisms. Further projects will be ...
16-Aug-2010 - The names of the finalists in this year’s European Biotechnica Award have been announced. The companies Addex Pharmaceuticals (Switzerland), Apeiron Biologics (Austria) and Galapagos Genomics (Belgium) have made it through to the final round. Addex Pharmaceuticals, based in Plan-Les-Ouates (near ...
05-Feb-2010 - Apeiron Biologics AG announced the signing of an agreement granting GlaxoSmithKline (GSK) exclusive rights to APN01 (recombinant human Angiotensin Converting Enzyme 2, rhACE2), an enzyme biotherapeutic currently in Phase 1 development for the treatment of the Acute Respiratory Distress Syndrome ...
17-Feb-2006 - Evotec AG and Apeiron Biologics GmbH announced that they have entered into a discovery collaboration to develop small molecules targeting a novel therapeutic concept for pain relief. This concept is based on research activities of Prof Josef Penninger, Director of the Institute for Molecular ...
© 1997-2024 LUMITOS AG, All rights reserved